(HealthDay News) — Despite smaller, prior studies suggesting that pioglitazone might raise users’ risk of bladder cancer, a large new study finds no statistically significant association. The research ...
NEW YORK (Reuters Health) - A review of official reports of bad drug reactions is revealing more signs that people taking the diabetes drug Actos are at higher risk of developing bladder cancer.
LAS VEGAS (AP) — A jury in Las Vegas ruled against two Nevada women after a three-month civil product liability trial alleging the maker of the diabetes drug Actos caused their bladder cancer. The ...
LOS ANGELES (Reuters) - The U.S. Food and Drug Administration said on Friday its has begun a safety review of diabetes drug Actos after receiving early results from a long-term study designed to ...
LAFAYETTE, La., April 8, 2014 /PRNewswire/ -- A Louisiana jury has awarded $9 billion to a New York man and his wife following a trial over the man's claims that his bladder cancer was caused by the ...
Connecticut attorneys at The Reardon Law Firm have a message for product liability lawyers and the makers of the Type 2 diabetes drug Actos, which has been linked to bladder cancer: The multidistrict ...
Cancer Monthly is reporting on new research published by PLoS One suggesting that the diabetes drug Actos, which is already associated with an increased risk of bladder cancer, may also increase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback